Back

Ibrutinib modulates CD19 expression and improves efficacy of CD19-CAR T cells in B-cell lymphoma models

Wang, S.; Arribas, A. J.; Tarantelli, C.; Civanelli, E.; Zhou, G.; Purwar, P.; Pradier, A.; Melotti, A.; Guidetti, F.; Hajj Younes, Y.; Terzi Di Bergamo, L.; Cascione, L.; Napoli, S.; Zucca, E.; Sotillo, E.; Mackall, C.; Esteller, M.; Chalandon, Y.; Rossi, D.; Simonetta, F.; Bertoni, F.

2026-05-26 immunology
10.64898/2026.05.22.727139 bioRxiv
Show abstract

Antigen density critically influences CAR T-cell efficacy. We show that ibrutinib induces CD19 upregulation in B-cell lymphoma models, enhancing CAR T-cell cytotoxicity. Pharmacologic modulation of target antigen expression represents a promising strategy to overcome resistance.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Blood Advances
54 papers in training set
Top 0.2%
10.1%
2
Leukemia
39 papers in training set
Top 0.1%
8.4%
3
Nature Communications
4913 papers in training set
Top 33%
4.8%
4
eLife
5422 papers in training set
Top 17%
4.8%
5
PLOS Pathogens
721 papers in training set
Top 3%
4.8%
6
OncoImmunology
22 papers in training set
Top 0.1%
4.6%
7
Cancer Immunology Research
34 papers in training set
Top 0.1%
4.3%
8
Journal of Clinical Investigation
164 papers in training set
Top 0.6%
4.3%
9
Frontiers in Immunology
586 papers in training set
Top 2%
3.6%
10
Blood Cancer Journal
11 papers in training set
Top 0.1%
3.2%
50% of probability mass above
11
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.4%
3.2%
12
Cancers
200 papers in training set
Top 3%
1.8%
13
Scientific Reports
3102 papers in training set
Top 55%
1.8%
14
Cell Reports Medicine
140 papers in training set
Top 4%
1.7%
15
PLOS ONE
4510 papers in training set
Top 54%
1.7%
16
Journal of Experimental Medicine
106 papers in training set
Top 2%
1.5%
17
Oncogene
76 papers in training set
Top 1%
1.5%
18
Gastroenterology
40 papers in training set
Top 1%
1.5%
19
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 37%
1.3%
20
eBioMedicine
130 papers in training set
Top 2%
1.3%
21
Blood
67 papers in training set
Top 1.0%
1.2%
22
Clinical Cancer Research
58 papers in training set
Top 1%
1.2%
23
Frontiers in Oncology
95 papers in training set
Top 3%
1.1%
24
European Journal of Immunology
57 papers in training set
Top 0.4%
0.9%
25
Cellular & Molecular Immunology
14 papers in training set
Top 2%
0.8%
26
Molecular Therapy
71 papers in training set
Top 3%
0.7%
27
Science Advances
1098 papers in training set
Top 32%
0.7%
28
EBioMedicine
39 papers in training set
Top 1%
0.7%
29
JCI Insight
241 papers in training set
Top 8%
0.7%
30
Communications Biology
886 papers in training set
Top 26%
0.7%